152 – Inside Alzheimer’s Research: New Medications and Innovative Care

Dr. Jason Karlawish, a renowned geriatrician and Alzheimer’s expert from the University of Pennsylvania, dives into the latest breakthroughs in Alzheimer’s medications like lecanemab and donanemab. They discuss how biomarkers revolutionize diagnosing Alzheimer’s and analyze the effectiveness of these new treatments. Ethical dilemmas surrounding lecanemab’s use are also explored, alongside the complexities families face in navigating care choices. Expect insights on the evolving landscape of Alzheimer’s research and pragmatic strategies for caregivers.